A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001)

NCT02279875 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

113

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Tuberculosis

Interventions

DRUG: Linezolid
DRUG: HRZE (isoniazid rifampicin,pyrazinamide,ethambutol)

Sponsor

Global Alliance for TB Drug Development